Prestige Consumer Healthcare Full Year 2025 Earnings: EPS Misses Expectations
Prestige Consumer Healthcare | 10-K: Annual report
William Blair Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating
Express News | Prestige Consumer Healthcare Inc : Canaccord Genuity Raises Target Price to $105 From $100
Prestige Consumer Healthcare Shares Are Trading Higher After the Company Reported a Q4 Adjusted EPS Beat.
William Blair Sticks to Its Buy Rating for Prestige Consumer Healthcare (PBH)
Prestige Consumer Healthcare Inc. Reports Record Q4 Revenue of $296.5 Million and Fiscal Year 2025 Results With Strong EPS Growth and Positive Outlook for Fiscal 2026
Express News | Prestige Consumer Healthcare : Currently Anticipate About $15 Mln Headwind Related to Inflationary Impacts of Enacted Tariffs to Date
Prestige Consumer Healthcare Sees FY26 Adj EPS $4.70-Adj EPS $4.82
Earnings Flash (PBH) Prestige Consumer Healthcare Posts Q4 Adjusted EPS $1.32, Vs. FactSet Est of $1.30
Prestige Consumer Q4 Adj. EPS $1.32 Beats $1.30 Estimate, Sales $276.99M Miss $289.35M Estimate
Express News | Prestige Consumer Healthcare Outlook FY Organic Growth 1-2%
Express News | Prestige Consumer Healthcare Q4 Operating Expenses USD 81.582 Million
Express News | Prestige Consumer Healthcare Q4 Pretax Profit USD 73.959 Million Vs. IBES Estimate USD 84.9 Million
Express News | Prestige Consumer Healthcare Q4 Gross Profit USD 170.01 Million
Prestige Consumer Hlthcr 4Q Rev $296.5M >PBH
Press Release: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
Earnings Preview: PBH to Report Financial Results Pre-market on May 08
Generational Group Announces Sale of Denmark Sausage Co. to Premium Brands